(Q44515894)

3 December 2017

title

Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex (English)

1 reference

3 December 2017

1 reference

Wolff A

1

1 reference

3 December 2017

Technau A

2

1 reference

3 December 2017

Ihling C

3

1 reference

3 December 2017

Technau-Ihling K

4

1 reference

3 December 2017

Erber R

5

1 reference

3 December 2017

Bosch FX

6

1 reference

3 December 2017

Brandner G

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

3 December 2017

1 reference

3 December 2017

volume

20

1 reference

3 December 2017

issue

11

1 reference

3 December 2017

page(s)

1307-1317

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

3 December 2017

1 reference

ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Regulation of p53 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Characterization of a new intrabody directed against the N-terminal region of human p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Regulation of the specific DNA binding function of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Twenty years of p53 research: structural and functional aspects of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

How p53 binds DNA as a tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Regulation of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

Cytoplasmically "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

mdm2 expression is induced by wild type p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Pharmacological rescue of mutant p53 conformation and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Transformation-related cellular protein p53: increased level in untransformed rat cells following treatment with the tumorpromoter, tetradecanoylphorbol-acetate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Signaling to p53: breaking the MDM2-p53 circuit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Human neuroblastoma: from basic science to clinical debut of cellular oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204251

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204251

1 reference

Dimensions Publication ID

3 December 2017

1049596128

0 references

Fatcat ID

release_tujz4vafobhtreyfgrwxg3fj3e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tujz4vafobhtreyfgrwxg3fj3e

24 November 2022

mapped directly with Wikidata item

1 reference